These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 35745097)

  • 21. Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association?
    Miptah HN; Ramli AS; Mohamad M; Hashim H; Tharek Z
    BMC Fam Pract; 2020 Nov; 21(1):238. PubMed ID: 33218301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between dietary intake and the presence of the metabolic syndrome in patients with non-alcoholic fatty liver disease.
    Georgoulis M; Kontogianni MD; Margariti A; Tiniakos D; Fragopoulou E; Zafiropoulou R; Papatheodoridis G
    J Hum Nutr Diet; 2015 Aug; 28(4):409-15. PubMed ID: 25988570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender-specific, Lifestyle-related Factors and 10-year Cardiovascular Disease Risk; the ATTICA and GREECS Cohort Studies.
    Kouvari M; Panagiotakos DB; Chrysohoou C; Georgousopoulou E; Notara V; Tousoulis D; Pitsavos C; Attica Greecs Studies Investigators
    Curr Vasc Pharmacol; 2019; 17(4):401-410. PubMed ID: 29886832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance is related with liver fibrosis in type 2 diabetic patients with non-alcoholic fatty liver disease proven biopsy and Mediterranean diet pattern as a protective factor.
    Aller R; Sigüenza R; Pina M; Laserna C; Antolín B; Burgueño B; Durà M; Izaola O; Primo D; de Luis DA
    Endocrine; 2020 Jun; 68(3):557-563. PubMed ID: 32239453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease.
    Wang B; Zhao Z; Liu S; Wang S; Chen Y; Xu Y; Xu M; Wang W; Ning G; Li M; Wang T; Bi Y
    Diabetes Res Clin Pract; 2021 Jul; 177():108873. PubMed ID: 34051282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease.
    Ishido S; Tamaki N; Takahashi Y; Uchihara N; Suzuki K; Tanaka Y; Miyamoto H; Yamada M; Matsumoto H; Nobusawa T; Keitoku T; Takaura K; Tanaka S; Maeyashiki C; Yasui Y; Tsuchiya K; Nakanishi H; Kurosaki M; Izumi N
    BMC Gastroenterol; 2023 Jun; 23(1):211. PubMed ID: 37330485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis.
    Haigh L; Kirk C; El Gendy K; Gallacher J; Errington L; Mathers JC; Anstee QM
    Clin Nutr; 2022 Sep; 41(9):1913-1931. PubMed ID: 35947894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the role of depression and anxiety on cardiovascular disease risk, using structural equation modeling; the mediating effect of the Mediterranean diet and physical activity: the ATTICA study.
    Antonogeorgos G; Panagiotakos DB; Pitsavos C; Papageorgiou C; Chrysohoou C; Papadimitriou GN; Stefanadis C
    Ann Epidemiol; 2012 Sep; 22(9):630-7. PubMed ID: 22831995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance.
    Baratta F; Pastori D; Polimeni L; Bucci T; Ceci F; Calabrese C; Ernesti I; Pannitteri G; Violi F; Angelico F; Del Ben M
    Am J Gastroenterol; 2017 Dec; 112(12):1832-1839. PubMed ID: 29063908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective association between adherence to the Mediterranean diet and hepatic steatosis: the Swiss CoLaus cohort study.
    Khalatbari-Soltani S; Marques-Vidal P; Imamura F; Forouhi NG
    BMJ Open; 2020 Dec; 10(12):e040959. PubMed ID: 33371031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.
    Luo J; Xu L; Li J; Zhao S
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):193-9. PubMed ID: 25563143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediterranean Diet and Cardiovascular Disease: The Moderating Role of Adequate Sleep-Results from the ATTICA Cohort Study (2002-2022).
    Damigou E; Chrysohoou C; Vafia C; Barkas F; Kravvariti E; Vlachopoulou E; Kyrili K; Tsioufis C; Pitsavos C; Liberopoulos E; Sfikakis PP; Panagiotakos D
    Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
    van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
    Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coffee consumption is not associated with prevalent subclinical cardiovascular disease (CVD) or the risk of CVD events, in nonalcoholic fatty liver disease: results from the multi-ethnic study of atherosclerosis.
    Simon TG; Trejo MEP; Zeb I; Frazier-Wood AC; McClelland RL; Chung RT; Budoff MJ
    Metabolism; 2017 Oct; 75():1-5. PubMed ID: 28964324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-inflammatory diet and 10-year (2002-2012) cardiovascular disease incidence: The ATTICA study.
    Georgousopoulou EN; Kouli GM; Panagiotakos DB; Kalogeropoulou A; Zana A; Chrysohoou C; Tsigos C; Tousoulis D; Stefanadis C; Pitsavos C
    Int J Cardiol; 2016 Nov; 222():473-478. PubMed ID: 27505336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance.
    Fiorentino TV; Succurro E; Sciacqua A; Andreozzi F; Perticone F; Sesti G
    Diabetes Metab Res Rev; 2020 Nov; 36(8):e3333. PubMed ID: 32356922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features.
    Bullón-Vela V; Abete I; Tur JA; Pintó X; Corbella E; Martínez-González MA; Toledo E; Corella D; Macías M; Tinahones F; Fitó M; Estruch R; Ros E; Salas-Salvadó J; Daimiel L; Zulet MA; Martínez JA;
    Nutrition; 2020 Mar; 71():110620. PubMed ID: 31838461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.
    Arvind A; Henson JB; Osganian SA; Nath C; Steinhagen LM; Memel ZN; Donovan A; Balogun O; Chung RT; Simon TG; Corey KE
    Hepatol Commun; 2022 Feb; 6(2):309-319. PubMed ID: 34558862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Food Compass Score predicts incident cardiovascular disease: The ATTICA cohort study (2002-2022).
    Damigou E; Detopoulou P; Antonopoulou S; Chrysohoou C; Barkas F; Vlachopoulou E; Vafia C; Tsioufis C; Liberopoulos E; Sfikakis PP; Pitsavos C; Panagiotakos D
    J Hum Nutr Diet; 2024 Feb; 37(1):203-216. PubMed ID: 37908110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NAFLD and MAFLD independently increase the risk of major adverse cardiovascular events (MACE): a 20-year longitudinal follow-up study from regional Australia.
    Vaz K; Kemp W; Majeed A; Lubel J; Magliano DJ; Glenister KM; Bourke L; Simmons D; Roberts SK
    Hepatol Int; 2024 Aug; 18(4):1135-1143. PubMed ID: 39008030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.